Literature DB >> 15902400

Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.

L Li1, W El-Kholy, C J Rhodes, P L Brubaker.   

Abstract

AIMS/HYPOTHESIS: The gut hormone glucagon-like peptide-1 (GLP-1) decreases beta cell apoptosis in a protein kinase B (PKB)-dependent fashion, and increases islet cell mass and function in vivo. In contrast, cytokines induce beta cell apoptosis, leading to decreased islet mass and type 1 diabetes. In the present study we used rat INS-1E beta cells and primary rat islet cells to examine the potential role of PKB as a mediator of the effect of GLP-1 on cytokine-induced apoptosis.
METHODS: Cell viability was determined by MTT assay, and apoptosis and necrosis by Hoechst 33342-propidium iodide staining. Immunoblot analysis was used to detect changes in protein expression, including active (phosphorylated) and total PKB, phosphorylated and total glycogen synthase kinase-3beta, activated caspase-3 and inducible nitric oxide synthase. Reactive oxygen species were determined by 1,7-dichlorofluorescein (DCF) analysis, and mutant forms of PKB were introduced into cells using adenoviral vectors.
RESULTS: Incubation of INS-1E cells with cytokines (IL-1beta, TNF-alpha and interferon-gamma; 10-50 ng/ml) for 18 h significantly decreased cell viability (by 44%, p<0.001), cell proliferation (by 80%, p<0.001), and activation of PKB (by 67%, p<0.001). Pre-treatment with exendin-4 (10(-7) mol/l), a long-acting GLP-1 receptor agonist, partially protected the cells against cytokine-induced toxicity (p<0.01) in association with a reduction in cytokine-induced inhibition of PKB phosphorylation (p<0.05). Exendin-4 pre-treatment did not change cell proliferation. Cytokine treatment increased apoptosis (by 156%, p<0.05) and necrosis (from undetectable to 2.6% of cells). These increases were both reduced by pre-treatment with exendin-4 (p<0.05-0.01). Furthermore, cytokine-induced apoptosis and necrosis were significantly increased in cells infected with kinase-dead PKB (p<0.05), and the protective effect of exendin-4 on both parameters was fully abolished in these cells. Similar changes were observed in primary islet cells. In parallel with these changes, exendin-4 decreased the cytokine-induced activation of caspase-3 (by 46%, p<0.05), and decreased levels of inducible nitric oxide synthase (by 71%, p<0.05) and reactive oxygen species (by 27%, p<0.05). CONCLUSIONS/
INTERPRETATION: The results of our study indicate that GLP-1 plays a protective role against cytokine-induced apoptosis and necrosis in beta cells through a PKB-dependent signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902400     DOI: 10.1007/s00125-005-1787-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  55 in total

1.  Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells.

Authors:  J Saldeen
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

2.  Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men.

Authors:  J Schirra; P Kuwert; U Wank; P Leicht; R Arnold; B Göke; M Katschinski
Journal:  Proc Assoc Am Physicians       Date:  1997-01

3.  Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.

Authors:  D A Stoffers; T J Kieffer; M A Hussain; D J Drucker; S Bonner-Weir; J F Habener; J M Egan
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

4.  Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.

Authors:  R L Tuttle; N S Gill; W Pugh; J P Lee; B Koeberlein; E E Furth; K S Polonsky; A Naji; M J Birnbaum
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

5.  In vivo visualization of oxygen radical-dependent photoemission.

Authors:  M Tsuchiya; M Suematsu; H Suzuki
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells.

Authors:  C A Delaney; D Pavlovic; A Hoorens; D G Pipeleers; D L Eizirik
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

7.  Upregulation of phosphoinositide 3-kinase and protein kinase B in alveolar macrophages following ozone inhalation. Role of NF-kappaB and STAT-1 in ozone-induced nitric oxide production and toxicity.

Authors:  Debra L Laskin; Ladan Fakhrzadeh; Diane E Heck; Donald Gerecke; Jeffrey D Laskin
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt?

Authors:  Lorna M Dickson; Christopher J Rhodes
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08       Impact factor: 4.310

9.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines.

Authors:  M Asfari; D Janjic; P Meda; G Li; P A Halban; C B Wollheim
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

10.  Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships.

Authors:  R Ritzel; C Orskov; J J Holst; M A Nauck
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

View more
  64 in total

1.  Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents.

Authors:  Krystyna Tatarkiewicz; Pamela A Smith; Emmanuel J Sablan; Clara J Polizzi; Donald E Aumann; Christiane Villescaz; Diane M Hargrove; Bronislava R Gedulin; Melissa G W Lu; Lisa Adams; Tina Whisenant; Denis Roy; David G Parkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-05       Impact factor: 4.310

2.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 3.  Recent advances in understanding the anti-diabetic actions of dietary flavonoids.

Authors:  Pon Velayutham Anandh Babu; Dongmin Liu; Elizabeth R Gilbert
Journal:  J Nutr Biochem       Date:  2013-09-09       Impact factor: 6.048

4.  NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells.

Authors:  Yoshiaki Tamura; Yuko Chiba; Toshihiro Tanioka; Nobuyuki Shimizu; Shohei Shinozaki; Marina Yamada; Kentaro Kaneki; Seijiro Mori; Atsushi Araki; Hideki Ito; Masao Kaneki
Journal:  FEBS Lett       Date:  2011-08-28       Impact factor: 4.124

5.  R-spondin-1 is a novel beta-cell growth factor and insulin secretagogue.

Authors:  Victor S C Wong; Andrea Yeung; William Schultz; Patricia L Brubaker
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

6.  Prevention of trauma/hemorrhagic shock-induced lung apoptosis by IL-6-mediated activation of Stat3.

Authors:  Ana Moran; Anna I Tsimelzon; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Susan G Hilsenbeck; Valeria Poli; David J Tweardy
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

7.  GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes.

Authors:  Hong Gao; Xinjun Wang; Zhiguo Zhang; Yisheng Yang; Jun Yang; Xiaoying Li; Guang Ning
Journal:  Endocrine       Date:  2007-10-02       Impact factor: 3.633

8.  Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6.

Authors:  Rozita Shirazi; Vilborg Palsdottir; Jim Collander; Fredrik Anesten; Heike Vogel; Fanny Langlet; Alexander Jaschke; Annette Schürmann; Vincent Prévot; Ruijin Shao; John-Olov Jansson; Karolina Patrycja Skibicka
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-18       Impact factor: 11.205

9.  Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.

Authors:  Marie-Line Peyot; Joshua P Gray; Julien Lamontagne; Peter J S Smith; George G Holz; S R Murthy Madiraju; Marc Prentki; Emma Heart
Journal:  PLoS One       Date:  2009-07-13       Impact factor: 3.240

10.  Incretin-based therapies: new treatments for type 2 diabetes in the new millennium.

Authors:  Joan Khoo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.